Clinical trials for Colorectal adenoma

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44336 clinical trials with a EudraCT protocol, of which 7366 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (18)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

18 result(s) found for: Colorectal adenoma. Displaying page 1 of 1.

EudraCT Number: 2011-001815-29

Sponsor Protocol Number: MDL_2011_36557

Start Date*: 2011-11-11

Sponsor Name:UMC Utrecht

Full Title: Chemopreventive effects of mesalazine in patients at high risk of recurrent (nonfamilial) colorectal adenomas

Medical condition: sporadic colorectal adenomas

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10069428	Colon adenomatous polyp	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Completed)

Trial results: (No results available)

EudraCT Number: 2006-001084-27

Sponsor Protocol Number: APAC

Start Date*: 2006-06-16

Sponsor Name:AZIENDA OSPEDALIERA OSPEDALI GALLIERA

Full Title: Phase I/II study of prevention of Colorectal Cancer CRC with Allopurinol in High-Risk Subjects

Medical condition: CHEMOPREVENTION OF COLORECTAL CANCER

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10048832	Colon adenoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-000693-31	Sponsor Protocol Number: COLO CP-01	Start Date*: 2005-06-17
Sponsor Name:Colotech A/S
Full Title: An international, multi centre, randomised, parallel group, prospective, double blind, placebo controlled clinical trial evaluating the efficacy and safety of a combination treatment administered o...
Medical condition: Patients who have had removal of polyp in colon or rectum within 3 months.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FI (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2011-005694-23

Sponsor Protocol Number: CB-17-01/05

Start Date*: 2011-12-20

Sponsor Name:COSMO TECHNOLOGIES LTD

Full Title: Polyp detection rate after single oral dose of methylene blue MMX(R) modified release tablets administered to subjects undergoing outpatients colonoscopy

Medical condition: patients scheduled for the screening or surveillance colonoscopy and meeting the joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer and the Ameri...

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10022891 - Investigations	10014805	Endoscopy	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10048832	Colon adenoma	PT
	14.1	10017947 - Gastrointestinal disorders	10048646	Polyp colorectal	PT

Population Age: Newborns, Infants and toddlers, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2019-003770-85	Sponsor Protocol Number: DKFZ-2019-007	Start Date*: 2020-08-20
Sponsor Name:German Cancer Research Center (DKFZ)
Full Title: Effect of low-dose acetylsalicylic acid on early detection of advanced colorectal neoplasms
Medical condition: Screening for advanced colorectal neoplasms. Male individuals aged 40 to 79 years scheduled for screening colonscopy and no use of acetylsalicylic acid (or other drugs with an effect on the blood ...
Disease:
Population Age: Adults, Elderly		Gender: Male
Trial protocol: DE (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2009-012115-18

Sponsor Protocol Number: IMP13617

Start Date*: 2010-03-22

Sponsor Name:UMC Utrecht

Full Title: Primovist enhanced MRI for the detection and evaluation of focal liver lesions

Medical condition: All benign and malignant focal liver lesions e.g. colorectal liver metastases, HCC, haemangioma, adenoma, cysts, FNH.

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10024658	Liver carcinoma	LLT
	12.0		10027479	Metastatic liver carcinoma	LLT
	12.0		10019827	Hepatocellular adenoma	LLT
	12.0		10049010	Carcinoma hepatocellular	LLT
	12.0		10019396	Hemangioma of liver	LLT
	12.0		10048834	Polycystic liver disease	LLT
	12.0		10052285	Focal nodular hyperplasia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2012-003983-32	Sponsor Protocol Number: CB-17-01/06	Start Date*: 2013-10-02
Sponsor Name:Cosmo Technologies Ltd
Full Title: The safety and efficacy of Methylene Blue MMX® modified release tablets administered to subjects undergoing screening or surveillance colonoscopy.
Medical condition: Polyp and adenoma detection during colonoscopy
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: IT (Completed) BE (Completed) DE (Completed) NL (Ongoing) LT (Completed)
Trial results: (No results available)

EudraCT Number: 2019-002562-12	Sponsor Protocol Number: ENDOS2019	Start Date*: 2019-09-09
Sponsor Name:HOSPITAL GENERAL DE CATALUNYA
Full Title: PRAGMATIC, COMPARATIVE AND RANDOMIZED CLINICAL TRIAL OF THE NEW SOLUTION OF 1 LITER POLYETHYLENE GLYCOL VERSUS SODIUM PICOSULFATE WITH MAGNESIUM CITRATE IN THE EFFECTIVENESS OF SCREENING AND SURVE...
Medical condition: Screening and surveillance colonoscopy
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2010-020943-10

Sponsor Protocol Number: GA10/9312

Start Date*: 2011-03-16

Sponsor Name:University of Leeds

Full Title: A randomised controlled trial of eicosapentaenoic acid (EPA) and/or aspirin for colorectal adenoma (or polyp) prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme...

Medical condition: colorectal adenoma (polyp)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004864	10048841	Bowel cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2022-000240-30	Sponsor Protocol Number: 80308	Start Date*: 2022-04-19
Sponsor Name:Center for Experimental and Molecular Medicine, G2 (AMC)
Full Title: The chemopreventive effect of Lithium on adenoma development in patients with familial adenomatous polyposis (FAP); a pilot study
Medical condition: Familial adenomatous polyposis
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: (No results available)

EudraCT Number: 2019-004840-30

Sponsor Protocol Number: PrepDial

Start Date*: 2020-11-04

Sponsor Name:Policlinico di Bari-UO Gastroenterologia

Full Title: Comparison of low-volume versus high-volume polyethylene glycol based bowel preparation for colonoscopy in people receiving hemodialysis: a randomized non-inferiority trial.

Medical condition: Colonoscopy in people receiving hemodialysis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.1	100000004848	10053099	Gastrointestinal function diagnostic procedures	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2006-001886-40

Sponsor Protocol Number: G2M-777 SYS 01/2004

Start Date*: 2006-06-06

Sponsor Name:TopoTarget Germany AG

Full Title: A randomized, double-blind, placebo-controlled parallel group study to assess the safety and efficacy of a new oral formulation of 2-propyl pentanoic acid (2-PPA, PEAC minitablets) for the treatmen...

Medical condition: Familial adenomatous polyposis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.1		10059327		LLT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: View results

EudraCT Number: 2006-002228-40	Sponsor Protocol Number: A3191193	Start Date*: 2006-08-28
Sponsor Name:PFIZER
Full Title: A PHASE III PLACEBO-CONTROLLED TRIAL OF CELECOXIB IN GENOTYPE POSITIVE SUBJECTS WITH FAMILIAL ADENOMATOUS POLYPOSIS
Medical condition: FAMILIAL ADENOMATOUS POLYPOSIS (FAP)
Disease:
Population Age: Children, Adolescents, Under 18		Gender: Male, Female
Trial protocol: ES (Prematurely Ended) SE (Completed) IT (Prematurely Ended) GB (Completed) CZ (Prematurely Ended) BE (Prematurely Ended) DE (Completed) HU (Prematurely Ended) SK (Completed) BG (Not Authorised)
Trial results: View results

EudraCT Number: 2021-000270-28	Sponsor Protocol Number: NL75171.058.20	Start Date*: 2022-06-30
Sponsor Name:Leiden University Medical Center
Full Title: Selective Indocyanine Green Injection of a Segmental Hepatic Artery Followed by Near-Infrared Fluorescence Guided Anatomical Liver Resection: A Feasibility Study
Medical condition: Hepatocellular carcinoma, hepatic adenoma, intrahepatic cholangiocarcinoma, colorectal liver metastases
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: (No results available)

EudraCT Number: 2015-004824-77

Sponsor Protocol Number: 27UCS2015

Start Date*: 2016-06-23

Sponsor Name:ENTE OSPEDALIERO OSPEDALI GALLIERA

Full Title: A randomized, phase II, double-blind, placebo-controlled, multicenter, 2x2 factorial design biomarker tertiary prevention trial of low-dose aspirin and metformin in resected stage I-III colorectal ...

Medical condition: Surgical resected colorectal cancer (stage I-III)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029104	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	SOC

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended) AT (Completed)

Trial results: (No results available)

EudraCT Number: 2006-002836-18

Sponsor Protocol Number: EPA/POL/03

Start Date*: 2006-10-09

Sponsor Name:S.L.A. Pharma (UK) Ltd

Full Title: A Two-Arm Chemoprevention Trial in Familial Adenomatous Polyposis Coli Patients Using the Purified Free Fatty Acid, Eicosapentaenoic Acid.

Medical condition: Familial adenomatous polyposis (FAP)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10059327	Familial adenomatous polyposis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2022-000339-21

Sponsor Protocol Number: JK08.1.01

Start Date*: 2022-08-29

Sponsor Name:Salubris Biotherapeutics, Inc.

Full Title: A Phase 1/2, Multicenter, Open Label, Dose Escalation & Dose Expansion Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, Monotherapy or in Combination in Patients with Unresectable ...

Medical condition: Unresectable Locally Advanced or Metastatic Cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041067	Small cell lung cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10053571	Melanoma	LLT
	24.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10085663	Clear cell papillary renal cell carcinoma	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10077840	Urothelial cancer of renal pelvis	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10067821	Head and neck cancer	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10075566	Triple negative breast cancer	PT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10030137	Oesophageal adenocarcinoma	PT
	25.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061534	Oesophageal squamous cell carcinoma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10040810	Skin carcinoma	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10051971	Pancreatic adenocarcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10073071	Hepatocellular carcinoma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10033128	Ovarian cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008229	Cervical cancer	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10014720	Endometrial adenocarcinoma	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10066474	Thyroid cancer	PT
	23.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10083238	Luminal breast cancer	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061451	Colorectal cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10071114	Metastatic gastric adenocarcinoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Trial now transitioned) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2019-002856-18

Sponsor Protocol Number: Mannitol_03-2018

Start Date*: 2020-06-04

Sponsor Name:NTC s.r.l.

Full Title: Efficacy and Safety of mAnniTol in bowel preparation: assessment of adequacy and presence of Intestinal levelS of hydrogen and methane during elective colonoscopy aFter mAnnitol or standard split 2...

Medical condition: Subjects scheduled for elective colonoscopy to be prepared and performed according to ESGE (European Society of Gastrointestinal Endoscopy - ESGE) guidelines.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	10022891 - Investigations	10010007	Colonoscopy	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) DE (Completed) IT (Completed)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Fri May 16 14:48:57 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA